Congress Materials – Winter Clinical Hawaii 2025
2025 Winter Clinical Hawaii | Feb 14-19 | Big Island, Waikoloa Village, HI
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
SPECTREM: Guselkumab Demonstrates Consistent Complete Clearance at Week 16 Across Special Sites in Participants with Low Body Surface Area, Moderate Psoriasis
Brad P. Glick, Jennifer Beecker, Javier Alonso-Llamazares, Angela Moore, Theodore Alkousakis, Kush Shah, Olivia Choi, Daphne Chan, Laura Park-Wyllie, Jenny Jeyarajah, Katelyn Rowland, Geeta Yadav, H. Chih-ho Hong
SPECTREM: Guselkumab Efficacy at Multiple High-Impact Sites in Participants With Low BSA, Moderate Plaque Psoriasis
H Nguyen, N Seminara, H Yu, T Alkousakis, O Choi, K Rowland, D Chan, J Jeyarajah, A Moore, L Albrecht
Sustained Improvements in Psoriasis Area and Severity Index and in Percent Body Surface Area of Psoriasis With JNJ-77242113 in Patients With Moderate-to-Severe Plaque Psoriasis: Treat-to-Target Analyses in the FRONTIER 1 & 2 Studies
Kim A. Papp, Laura K. Ferris, Andreas Pinter, Phoebe Rich, Ronald B. Vender, Andrew E. Pink, Takayuki Ota, Yaung-Kaung Shen, Shu Li, Amy M. DeLozier, Ya-Wen Yang, Robert Bissonnette
THE POWER OF IMAGERY IN CLINICAL MEDICINE: LEVERAGING CLINICAL PHOTOS FROM THE VISIBLE STUDY TO FOSTER CONVERSATIONS BETWEEN CLINICIANS AND PATIENTS
Adrian O Rodriguez, Linda Stein Gold, Mona Shahriari, Andrew Alexis, Olivia Choi, Daphne Chan, Theodore Alkousakis, Elizabeth Skobelev, Sancharitha Ramji, Amy McMichael, Susan C Taylor, Seemal R Desai
VISIBLE (COHORT B): GUSELKUMAB DEMONSTRATES COMPARABLE 1-YEAR EFFICACY IN MODERATE-TO-SEVERE SCALP PSORIASIS PARTICIPANTS WITH HIGH VS LOW BASELINE BODY SURFACE AREA INVOLVEMENT
L. Stein Gold, M. Shahriari, M. Sauder, K. Shah, T. Alkousakis, O. Choi, K. Rowland, D. Chan, T. Ma, G. Yadav, A. McMichael, A. Alexis
VISIBLE COHORT B: GUSELKUMAB IMPROVES SCALING, ITCH, AND SHEDDING OR FLAKING THROUGH WEEK 48 IN PARTICIPANTS WITH MODERATE-TO-SEVERE SCALP PSORIASIS
A. Shahbaz, D. Ruiz Dasilva, N. Duffy, O. Choi, T. Alkousakis, K. Rowland, D. Chan, T. Ma, Y.J. Kim, R. Seervai, R. Gupta, J.K. Tung, S.G. Kwatra, A. McMichael
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.